🏋️Muscle Growth & Performance

A synthetic hexapeptide growth hormone secretagogue considered to offer the best balance of potency and side effect profile among the GHRP family.

A modified version of insulin-like growth factor 1 with an extended half-life, potently promoting muscle growth, hyperplasia, and recovery through direct anabolic signaling.

A synthetic tetrapeptide based on the natural epithalamin peptide from the pineal gland, studied for its ability to activate telomerase and potentially slow cellular aging.

A synthetic hexapeptide growth hormone secretagogue that potently stimulates GH release through the ghrelin receptor, with additional cardioprotective properties.

A glycoprotein that inhibits myostatin and activin, removing the body's natural brake on muscle growth and enabling significant increases in lean muscle mass.

A class of biological agents that block myostatin (GDF-8), the body's primary muscle growth inhibitor, enabling significant increases in muscle mass — the 'holy grail' of muscle-building therapeutics.

A truncated form of IGF-1 missing the first 3 amino acids, resulting in 5-10x greater potency than native IGF-1 due to dramatically reduced binding protein affinity, with rapid and localized anabolic effects.

A splice variant of IGF-1 produced locally in damaged muscle tissue that activates satellite cells and initiates muscle repair and growth following mechanical stress.

FDA-approved melanocortin-4 receptor (MC4R) agonist for rare genetic obesity disorders. Targets the brain's hunger signaling pathway to reduce appetite and increase energy expenditure.

A soluble activin receptor type IIB fusion protein that acts as a myostatin trap, promoting significant muscle growth by intercepting growth-limiting signals before they reach muscle cells.

The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.

A long-acting growth hormone-releasing hormone (GHRH) analog with a Drug Affinity Complex that extends its half-life to 6-8 days, producing sustained elevated growth hormone and IGF-1 levels.

A synergistic combination of tesamorelin (GHRH analogue) and ipamorelin (selective GHRP) that amplifies growth hormone release through dual-pathway stimulation, widely considered the gold standard GH peptide stack.

A 51-amino acid peptide hormone produced by pancreatic beta cells that regulates blood glucose, promotes nutrient uptake into cells, and is used medically for diabetes and off-label in bodybuilding as a powerful anabolic agent.

A popular clinical combination of two growth hormone secretagogues that work through complementary pathways — GHRH receptor (sermorelin) and ghrelin receptor (ipamorelin) — for synergistic GH release with minimal side effects.

A PEGylated version of Mechano Growth Factor with an extended half-life from minutes to hours, allowing systemic distribution and sustained satellite cell activation for muscle growth and repair.

FDA-approved synthetic analog of amylin, a peptide hormone co-secreted with insulin. Used alongside insulin for diabetes management, it slows gastric emptying, reduces glucagon, and promotes satiety — leading to weight loss.

A highly selective growth hormone-releasing peptide (GHRP) that stimulates GH release with minimal impact on cortisol, prolactin, or appetite, making it the cleanest GHRP available.

An orally active, non-peptide growth hormone secretagogue that mimics ghrelin to raise GH and IGF-1 levels for up to 24 hours per dose, with notable effects on sleep, appetite, and body composition.

A modified growth hormone-releasing hormone fragment with a short half-life (~30 minutes) that stimulates pulsatile growth hormone release, closely mimicking the body's natural GH secretion pattern.

An experimental oral growth hormone secretagogue peptide designed to stimulate GH release through the ghrelin receptor, offering a potential alternative to injectable GH-releasing peptides.

An FDA-approved synthetic analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification, indicated for HIV-associated lipodystrophy and studied for cognitive benefits and visceral fat reduction.

The nasal spray formulation of bremelanotide (PT-141) for convenient administration. Activates melanocortin receptors in the brain to increase sexual desire.

A synthetic analog of vasopressin (antidiuretic hormone) that is one of the most widely prescribed peptide drugs worldwide. Used for diabetes insipidus, bedwetting, and bleeding disorders.

FDA-approved 14-amino acid peptide for IBS-C and chronic constipation. Activates guanylate cyclase-C receptors to increase fluid secretion and reduce visceral pain.

A lipidated copper peptide derivative optimized for topical penetration, promoting collagen synthesis and skin regeneration more effectively than standard GHK-Cu.

FDA-approved PTHrP analog for osteoporosis. Stimulates new bone formation with potentially fewer side effects than teriparatide. Daily injection.

FDA-approved guanylate cyclase-C agonist peptide for chronic idiopathic constipation and IBS-C. Mimics uroguanylin to increase intestinal fluid secretion.

FDA-approved synthetic alpha-MSH analog that increases melanin production. Used for erythropoietic protoporphyria and investigated for vitiligo and sun protection.

FDA-approved nasal spray form of glucagon for emergency hypoglycemia treatment. Revolutionary needle-free delivery for diabetic emergencies.

FDA-approved monoclonal antibody/peptide for thyroid eye disease. First targeted therapy for this condition. Inhibits IGF-1 receptor signaling.

FDA-approved GLP-1 receptor agonist for type 2 diabetes. Shorter-acting than semaglutide with strong post-meal glucose control.

FDA-approved oral growth hormone secretagogue used as a diagnostic test for adult GH deficiency. The only FDA-approved oral GHS.

A synthetic 20-amino acid peptide that directly inhibits thrombin. FDA-approved anticoagulant used during cardiac procedures.

A neuropeptide related to somatostatin that regulates inflammation, sleep, and cortical activity. Shows promise for autoimmune and inflammatory conditions.

A cyclic heptapeptide derived from rattlesnake venom. FDA-approved antiplatelet agent for acute coronary syndromes.

Recombinant B-type natriuretic peptide FDA-approved for acute decompensated heart failure. Promotes vasodilation and diuresis.

A macrocyclic peptide complement C5 inhibitor approved for myasthenia gravis. Represents a new class of peptide-based complement inhibitors.

A 36-amino acid synthetic peptide that blocks HIV from entering cells. First fusion inhibitor approved for HIV treatment.

A synthetic peptide-based erythropoiesis-stimulating agent (ESA) that mimics EPO. Stimulates red blood cell production for anemia management.

A bicyclic peptide HDAC inhibitor FDA-approved for cutaneous T-cell lymphoma. Represents peptides in cancer therapy.

The first 29 amino acids of natural GHRH, previously FDA-approved for pediatric GH deficiency. Now widely used off-label for anti-aging GH optimization as a safer alternative to direct HGH therapy.

A naturally occurring dipeptide of beta-alanine and histidine found in high concentrations in muscle and brain tissue, with antioxidant, anti-glycation, and anti-aging properties.

A synthetic hexapeptide growth hormone secretagogue that stimulates GH release through the ghrelin receptor (GHS-R1a), notable for its potent GH-releasing effects and strong appetite stimulation.

A modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and inhibits lipogenesis without the diabetogenic or growth-promoting effects of full-length HGH.

A PEGylated growth hormone receptor antagonist that blocks GH action at the receptor level, used to treat acromegaly by normalizing IGF-1 levels without reducing GH secretion.

A class of molecules that boost cellular NAD+ levels to support energy metabolism, DNA repair, sirtuin activation, and anti-aging pathways — while not peptides themselves, they are commonly discussed alongside anti-aging peptides.

The endogenous hypothalamic decapeptide that controls reproductive hormone release, used clinically for fertility treatment and diagnostics, and in TRT protocols to maintain testicular function.

A modified fragment of human growth hormone (amino acids 176-191) that specifically promotes fat metabolism and lipolysis without the growth-promoting or diabetogenic effects of full HGH.

A synthetic GnRH agonist decapeptide used medically for prostate cancer, endometriosis, and off-label for PCT (post-cycle therapy) to restart the hypothalamic-pituitary-gonadal axis after anabolic steroid use.

A 10-amino acid fragment of kisspeptin that is the most potent endogenous stimulator of GnRH release, playing a critical role in reproductive hormone regulation and fertility.

An endogenous peptide ligand for the APJ receptor involved in cardiovascular regulation, fluid homeostasis, angiogenesis, and energy metabolism, with therapeutic potential for heart failure.

A small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that promotes fat loss by increasing NAD+ levels and cellular energy metabolism, available as an oral compound.

A triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) originally developed for Parkinson's and Alzheimer's disease, repurposed as a potent weight-loss agent.

A 29-amino acid peptide hormone produced by pancreatic alpha cells that raises blood glucose, promotes fat breakdown, and is used medically for severe hypoglycemia emergencies and diagnostically for GI imaging.